Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).
Clinical trial NCT00713518 · COMPLETED
Trial details
- NCT number
- NCT00713518
- Sponsor
- Quark Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-11-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.